This article has been cited by
1Hydrogen Bonding and Anticancer Properties of Water-Soluble Chiralp-Cymene RuIICompounds with Amino-Oxime Ligands
Yosra Benabdelouahab,Laura Muñoz-Moreno,Malgorzata Frik,Isabel de la Cueva-Alique,Mohammed Amin El Amrani,María Contel,Ana M. Bajo,Tomás Cuenca,Eva Royo
European Journal of Inorganic Chemistry.2015;2015(13)2295
[DOI]
2The implications of baseline bone-health assessment at initiation of androgen-deprivation therapy for prostate cancer
Peter S. Kirk,Tudor Borza,Vahakn B. Shahinian,Megan E.V. Caram,Danil V. Makarov,Jeremy B. Shelton,John T. Leppert,Ryan M. Blake,Jennifer A. Davis,Brent K. Hollenbeck,Anne Sales,Ted A. Skolarus
BJU International.2018;121(4)558
[DOI]
3Importance of the correct assessment of bone fractures in the clinical management of metastatic castration-resistant prostate cancer treated with radium-223: A case report
Elisa Lodi Rizzini,Pietro Ghedini,Raffaele Cardano,Chiara Bellarosa,Alessio Morganti,Stefano Fanti,Fabio Monari
Molecular and Clinical Oncology.2019;121(4)558
[DOI]
4Castration-induced bone loss triggers growth of disseminated prostate cancer cells in bone
P. D. Ottewell,N. Wang,J. Meek,C. A. Fowles,P. I. Croucher,C. L. Eaton,I. Holen
Endocrine Related Cancer.2014;21(5)769
[DOI]
5Évaluation de la réponse métabolique en TEP/TDM à la F18-FCH après un mois de traitement par acétate d’abiratérone chez les patients présentant un cancer de la prostate métastatique résistant à la castration
S. Boughdad,S. Le Moulec,C. Massard,F. Farace,P. Vielh,O. Aupée,D. Métivier,L. Védrine,E. Gontier
Médecine Nucléaire.2015;39(4)386
[DOI]
Feedback

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal